Annual ROE
-21.04%
+223.88%+91.41%
December 31, 2023
Summary
- As of February 7, 2025, SBFM annual return on equity is -21.04%, with the most recent change of +223.88% (+91.41%) on December 31, 2023.
- During the last 3 years, SBFM annual ROE has fallen by -312.63% (-107.22%).
- SBFM annual ROE is now -100.07% below its all-time high of 32.36 thousand%, reached on December 1, 2013.
Performance
SBFM ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-18.13%
-2.07%-12.89%
September 30, 2024
Summary
- As of February 7, 2025, SBFM quarterly return on equity is -18.13%, with the most recent change of -2.07% (-12.89%) on September 30, 2024.
- Over the past year, SBFM quarterly ROE has increased by +87.66% (+82.86%).
- SBFM quarterly ROE is now -100.87% below its all-time high of 2073.67%, reached on June 1, 2014.
Performance
SBFM Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
SBFM ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +91.4% | +82.9% |
| 3 y3 years | -107.2% | +80.7% |
| 5 y5 years | -100.5% | +80.7% |
SBFM ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +99.6% | -101.1% | +95.0% |
| 5 y | 5-year | -107.2% | +99.6% | -101.1% | +95.0% |
| alltime | all time | -100.1% | +99.6% | -100.9% | +99.8% |
Sunshine Biopharma ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -18.13%(+12.9%) |
| Jun 2024 | - | -16.06%(-13.1%) |
| Mar 2024 | - | -18.49%(-11.9%) |
| Dec 2023 | -21.04%(-91.4%) | -20.99%(-80.2%) |
| Sep 2023 | - | -105.79%(+12.4%) |
| Jun 2023 | - | -94.15%(-5.4%) |
| Mar 2023 | - | -99.57%(-12.6%) |
| Dec 2022 | -244.92%(-95.8%) | -113.88%(+740.4%) |
| Sep 2022 | - | -13.55%(-71.9%) |
| Jun 2022 | - | -48.23%(-86.6%) |
| Mar 2022 | - | -360.16%(-121.1%) |
| Dec 2021 | -5874.54%(-2114.7%) | - |
| Dec 2021 | - | 1704.04%(+22.7%) |
| Sep 2021 | - | 1388.95%(+11.0%) |
| Jun 2021 | - | 1251.48%(+13.0%) |
| Mar 2021 | - | 1107.63%(+181.4%) |
| Dec 2020 | 291.59%(+29.2%) | 393.62%(+22.5%) |
| Sep 2020 | - | 321.39%(+28.6%) |
| Jun 2020 | - | 249.98%(+20.9%) |
| Mar 2020 | - | 206.71%(-22.0%) |
| Dec 2019 | 225.77%(-94.2%) | 264.95%(-24.5%) |
| Sep 2019 | - | 350.84%(-57.8%) |
| Jun 2019 | - | 831.29%(-50.5%) |
| Mar 2019 | - | 1677.84%(+53.3%) |
| Dec 2018 | 3864.16%(+2030.1%) | 1094.66%(+76.1%) |
| Sep 2018 | - | 621.68%(+108.7%) |
| Jun 2018 | - | 297.87%(+37.1%) |
| Mar 2018 | - | 217.21%(-5.8%) |
| Dec 2017 | 181.41%(-89.1%) | 230.57%(-57.5%) |
| Sep 2017 | - | 542.22%(-69.4%) |
| Jun 2017 | - | 1774.57%(-8.8%) |
| Mar 2017 | - | 1945.21%(+10.0%) |
| Dec 2016 | 1667.48% | 1768.47%(+72.5%) |
| Sep 2016 | - | 1025.26%(+187.1%) |
| Jun 2016 | - | 357.11%(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2016 | - | 431.65%(-7.5%) |
| Dec 2015 | 276.87%(-44.5%) | 466.41%(+5.2%) |
| Sep 2015 | - | 443.44%(-9.9%) |
| Jun 2015 | - | 491.95%(-9.5%) |
| Mar 2015 | - | 543.33%(-19.5%) |
| Dec 2014 | 499.02%(-98.5%) | 674.66%(-44.5%) |
| Sep 2014 | - | 1214.63%(-41.4%) |
| Jun 2014 | - | 2073.67%(-125.0%) |
| Mar 2014 | - | -8284.86%(+251.4%) |
| Dec 2013 | 32.36 K%(-3317.4%) | -2357.93%(+47.9%) |
| Sep 2013 | - | -1593.85%(+28.2%) |
| Jun 2013 | - | -1243.55%(-7.3%) |
| Mar 2013 | - | -1341.61%(+121.2%) |
| Dec 2012 | -1005.68%(+86.2%) | -606.55%(-15.0%) |
| Sep 2012 | - | -713.75%(+31.8%) |
| Jun 2012 | - | -541.55%(+31.6%) |
| Mar 2012 | - | -411.65%(+15.9%) |
| Dec 2011 | -540.00%(+97.2%) | -355.14%(+13.9%) |
| Sep 2011 | - | -311.68%(-24.8%) |
| Jun 2011 | - | -414.36%(-79.1%) |
| Mar 2011 | - | -1980.51%(-34.3%) |
| Dec 2010 | -273.90%(-77.7%) | -3012.95%(-46.7%) |
| Sep 2010 | - | -5657.72%(+29.5%) |
| Jun 2010 | - | -4370.40%(+78.5%) |
| Mar 2010 | - | -2448.10%(-60.1%) |
| Dec 2009 | -1228.12%(-2197.6%) | - |
| Oct 2009 | - | -6141.87%(-7997.5%) |
| Jul 2009 | 58.55%(-66.7%) | 77.77%(-7.6%) |
| Apr 2009 | - | 84.15%(-43.1%) |
| Jan 2009 | - | 147.93%(-33.7%) |
| Oct 2008 | - | 223.17%(-58.9%) |
| Jul 2008 | 175.71%(-279.7%) | 543.23%(-63.1%) |
| Apr 2008 | - | 1471.15%(-557.2%) |
| Jan 2008 | - | -321.74%(+68.2%) |
| Oct 2007 | - | -191.30% |
| Jul 2007 | -97.76% | - |
FAQ
- What is Sunshine Biopharma annual return on equity?
- What is the all time high annual ROE for Sunshine Biopharma?
- What is Sunshine Biopharma annual ROE year-on-year change?
- What is Sunshine Biopharma quarterly return on equity?
- What is the all time high quarterly ROE for Sunshine Biopharma?
- What is Sunshine Biopharma quarterly ROE year-on-year change?
What is Sunshine Biopharma annual return on equity?
The current annual ROE of SBFM is -21.04%
What is the all time high annual ROE for Sunshine Biopharma?
Sunshine Biopharma all-time high annual return on equity is 32.36 K%
What is Sunshine Biopharma annual ROE year-on-year change?
Over the past year, SBFM annual return on equity has changed by +223.88% (+91.41%)
What is Sunshine Biopharma quarterly return on equity?
The current quarterly ROE of SBFM is -18.13%
What is the all time high quarterly ROE for Sunshine Biopharma?
Sunshine Biopharma all-time high quarterly return on equity is 2073.67%
What is Sunshine Biopharma quarterly ROE year-on-year change?
Over the past year, SBFM quarterly return on equity has changed by +87.66% (+82.86%)